» Articles » PMID: 28505239

FoxO1 Promotes Mitophagy in the Podocytes of Diabetic Male Mice Via the PINK1/Parkin Pathway

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2017 May 16
PMID 28505239
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

We recently showed that forkhead-box class O1 (FoxO1) activation protects against high glucose-induced injury by preventing mitochondrial dysfunction in the rat kidney cortex. In addition, FoxO1 has been reported to mediate putative kinase 1 (PINK1) transcription and promote autophagy in response to mitochondrial oxidative stress in murine cardiomyocytes. In this study, we ascertained whether overexpressing FoxO1 in the kidney cortex reverses preestablished diabetic nephropathy in animal models. The effect of FoxO1 on mitophagy signaling pathways was evaluated in mouse podocytes. In vivo experiments were performed in male KM mice. A mouse model of streptozotocin (STZ)-induced type 1 diabetes (T1D) was used, and lentiviral vectors were injected into the kidney cortex to overexpress FoxO1. A mouse podocyte cell line was treated with high concentrations of glucose and genetically modified using lentiviral vectors. We found aberrant mitochondrial morphology and reduced adenosine triphosphate production. These mitochondrial abnormalities were due to decreased mitophagy via reduced phosphatase/tensin homolog on chromosome 10-induced PINK1/Parkin-dependent signaling. FoxO1 upregulation and PINK1/Parkin pathway activation can individually restore injured podocytes in STZ-induced T1D mice. Our results link the antioxidative activity of FoxO1 with PINK1/Parkin-induced mitophagy, indicating a novel role of FoxO1 in diabetic nephropathy.

Citing Articles

Nicotinamide mononucleotide combined with PJ-34 protects microglial cells from lipopolysaccharide-induced mitochondrial impairment through NMNAT3-PARP1 axis.

Li J, Cheng X, Ma R, Zou B, Zhang Y, Wu M J Transl Med. 2025; 23(1):279.

PMID: 40050860 PMC: 11884077. DOI: 10.1186/s12967-025-06280-1.


Important regulatory role of mitophagy in diabetic microvascular complications.

Hu X, Lv J, Zhao Y, Li X, Qi W, Wang X J Transl Med. 2025; 23(1):269.

PMID: 40038741 PMC: 11877814. DOI: 10.1186/s12967-025-06307-7.


The Role of Mitochondria in Diabetic Kidney Disease and Potential Therapeutic Targets.

Takasu M, Kishi S, Nagasu H, Kidokoro K, Brooks C, Kashihara N Kidney Int Rep. 2025; 10(2):328-342.

PMID: 39990900 PMC: 11843125. DOI: 10.1016/j.ekir.2024.10.035.


Autophagy and Mitophagy in Diabetic Kidney Disease-A Literature Review.

Stanigut A, Tuta L, Pana C, Alexandrescu L, Suceveanu A, Blebea N Int J Mol Sci. 2025; 26(2).

PMID: 39859520 PMC: 11766107. DOI: 10.3390/ijms26020806.


Formula alleviates diabetic podocyte injury by regulating miR-21a-5p/FoxO1/PINK1-mediated mitochondrial autophagy.

Guo K, Li Y, Xuan C, Hou Z, Ye S, Li L Nan Fang Yi Ke Da Xue Xue Bao. 2025; 45(1):27-34.

PMID: 39819709 PMC: 11744282. DOI: 10.12122/j.issn.1673-4254.2025.01.04.